Cargando…
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Objective. To investigate the association between type 2 diabetes, glucose-lowering therapies (monotherapy with either metformin, sulphonylurea or insulin) and cancer risk in Taiwan. Methods. Using Taiwan's National Health Research Institutes database of 1,000,000 random subjects from 2000–2008...
Autores principales: | Hsieh, Ming-Chia, Lee, Tzu-Chi, Cheng, Shu-Min, Tu, Shih-Te, Yen, Ming-Hong, Tseng, Chin-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374948/ https://www.ncbi.nlm.nih.gov/pubmed/22719752 http://dx.doi.org/10.1155/2012/413782 |
Ejemplares similares
-
Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin‐Hsiao
Publicado: (2018) -
Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014) -
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016) -
Metformin Reduces the Risk of Diverticula of Intestine in Taiwanese Patients with Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2021) -
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)